An amoeba to help the eco-industry
Willaertia magna C2c MakyAmoéba develops applications by exploiting the characteristics of the amoeba Willaertia magna C2c Maky. This amoeba has been isolated from the environment and has natural properties.
Lastest news
13 March 2023
Initiation report from the analyst Edison Group
Amoéba announces that Edison Group, a London-based equity research house, has initiated coverage on the company.
16 February 2023
Submission of the building permit application for the 100% biocontrol manufacturing unit
Amoéba announces that it has applied for building permit for its new production site dedicated to biocontrol application, based in Cavaillon in the south of France.
15 February 2023
Signature of a new financing agreement with Nice & Green
Amoéba announces the signature of a new simple bond financing agreement of 9 million euros with the Swiss company Nice & Green SA.
27 January 2023
Cancellation of the issue of the 8th optional tranche of OCAs and signature of a support contract with Redbridge Debt and Treasury Advisory
Amoéba announces that it has terminated its convertible bond issue contract with Nice & Green SA and waived the issue of the 8th optional tranche of 80 OCAs. In order to adapt its financial strategy to its new industrial transformation challenges, Amoéba has concluded a contract with Redbridge Debt and Treasury Advisory to assist it in its search for financing.
Welcome @AmoebaNature as a featured exhibitor at the BioSolutions Conference & Expo!
Amoéba is an innovative #greentech company providing the industry with disruptive & sustainable solutions for key resource treatment. Learn more at http://ow.ly/icPi50Mzv8N
#BioSolutions
📣 Communiqué de presse : https://bit.ly/3RbfQHe
#Amoéba annonce l’annulation de l’émission de la 8° tranche optionnelle d’OCA et la signature d’un contrat avec Redbridge Debt and Treasury Advisory afin d’adapter sa stratégie financière aux enjeux de transformation industrielle
📣 Communiqué de presse : https://bit.ly/3X2hdKt
#Amoéba confirme son éligibilité au dispositif PEA-PME. Les #actions AMOEBA peuvent donc être intégrées dans les portefeuilles PEA PME, dédiés aux #investissements dans les #PME et #ETI selon les critères réglementaires.
🎥 @Fabrice Plasson, PDG d’#Amoéba, revient sur cette année exceptionnelle dans une vidéo dédiée au #bilan 2022 et aux #perspectives 2023. AMM, nouvelle usine, stratégie, plan de financement, tant de sujets abordés sur la chaîne #YouTube d’#Amoéba : https://bit.ly/3Wz75bz
Business
At the crossroads of environmental protection and public health issues, we are developing a three-fold scientific, industrial and commercial expertise. The company is developing around multiple applications using the amoeba Willaertia magna C2c Maky in the prevention of microbiological risk for water treatment, human wounds and plant protection.
Discover
Biocide
The only biological biocide that can be used in air cooling towers, with no hazard class for human health and the environment.
Water treatment
Our disruptive biocide helps control the level of Legionella, both those present in the water and those colonizing the biofilm.
The effectiveness of the biocide is due to the natural properties of the amoeba Willaertia magna C2c Maky, which predates pathogenic bacteria and other free-standing amoebae.
For the first time in 50 years of industrial water treatment, Amoéba is giving industry the opportunity to choose a responsible alternative.
Learn moreTestimonials
The industry professionals testify about their experiences with the biological biocide BIOMEBA.Dalkia
Vitacuire
Häagen Dazs
Research & Development
Other research is currently being conducted in order to make the best use of Willaertia magna C2c Maky’s different properties.
These properties open up a wide range of applications, particularly at the interface between health and environment fields.
All about it